血清甲胎蛋白：在肝脏疾病中的诊断意义
Serum alpha-fetoprotein: diagnostic significance in liver disease.
作者信息
Ruoslahti E, Salaspuro M, Pihko H, Andersson L, Seppälä M
出版信息
Br Med J. 1974 Jun 8;2(5918):527-9. doi: 10.1136/bmj.2.5918.527.
Abstract
Raised serum alpha-fetoprotein levels measured by radioimmunoassay were found in 19 out of 24 (79%) patients with primary liver cancer and in 32 out of 311 (10%) patients with other liver diseases. The rise was transient in cases of hepatitis and a transient rise was also seen after alcohol intake ceased in two patients with cirrhosis. alpha-Fetoprotein levels exceeding 500 ng/ml were 30-50 times more common in primary liver cancer than in other liver diseases. A rise in level seems to reflect the extent of liver regeneration in liver diseases other than primary cancer.
摘要
通过放射免疫测定法测得，24例原发性肝癌患者中有19例（79%）血清甲胎蛋白水平升高，311例其他肝病患者中有32例（10%）血清甲胎蛋白水平升高。肝炎患者的甲胎蛋白升高是暂时的，两名肝硬化患者在戒酒之后也出现了甲胎蛋白水平的暂时升高。原发性肝癌患者甲胎蛋白水平超过500纳克/毫升的情况比其他肝病患者多30至50倍。甲胎蛋白水平升高似乎反映了除原发性癌症之外其他肝病中的肝脏再生程度。
相似文献
1
Serum alpha-fetoprotein: diagnostic significance in liver disease.血清甲胎蛋白：在肝脏疾病中的诊断意义
Br Med J. 1974 Jun 8;2(5918):527-9. doi: 10.1136/bmj.2.5918.527.
2
[Alpha-1-fetoprotein--diagnostic significance. Determination using radioimmunoassay and migration-immunoelectrophoresis].
Schweiz Med Wochenschr. 1974 Apr 20;104(16):557-64.
3
Further observations on alpha-fetoprotein in the diagnosis of diseases of the digestive tract.关于甲胎蛋白在消化道疾病诊断中的进一步观察
Digestion. 1973;8(5):396-406. doi: 10.1159/000197343.
4
5
alpha-fetoprotein in noneoplastic hepatic disorders.非肿瘤性肝脏疾病中的甲胎蛋白
JAMA. 1975 Jul 7;233(1):38-41. doi: 10.1001/jama.233.1.38.
6
Alpha-fetoprotein in primary liver cancer and other diseases.原发性肝癌及其他疾病中的甲胎蛋白。
Gut. 1974 Oct;15(10):814-21. doi: 10.1136/gut.15.10.814.
7
[Future problems in the research of -fetoprotein].[甲胎蛋白研究中的未来问题]
Nihon Rinsho. 1972 May;30(5):1209-14.
8
[Significance of serum alpha-fetoprotein determination. Experiences with our own radioimmunoassay].[血清甲胎蛋白测定的意义。我们自身放射免疫测定法的经验]
Fortschr Med. 1976 Apr 22;94(12):702-10.
9
[Letter: Alpha1-fetoprotein].[信件：甲胎蛋白]
Dtsch Med Wochenschr. 1974 Dec 20;99(51):2623.
10
Alpha fetoprotein in hepatocellular disease and neoplastic disorders.肝细胞疾病和肿瘤性疾病中的甲胎蛋白
Am J Gastroenterol. 1974 Jan;61(1):45-52.
引用本文的文献
1
Discovery of a haptoglobin glycopeptides biomarker panel for early diagnosis of hepatocellular carcinoma.发现用于肝细胞癌早期诊断的触珠蛋白糖肽生物标志物 panel。
Front Oncol. 2023 Oct 18;13:1213898. doi: 10.3389/fonc.2023.1213898. eCollection 2023.
2
Input of serum haptoglobin fucosylation profile in the diagnosis of hepatocellular carcinoma in patients with non-cirrhotic liver disease.血清结合珠蛋白岩藻糖化谱在非肝硬化肝病患者肝细胞癌诊断中的应用。
Clin Res Hepatol Gastroenterol. 2020 Oct;44(5):681-691. doi: 10.1016/j.clinre.2019.12.010. Epub 2020 Jan 18.
3
Differentiation of acute and chronic hepatitis B in IgM anti-HBc positive patients.IgM抗-HBc阳性患者中急性和慢性乙型肝炎的鉴别
World J Gastroenterol. 2015 Apr 7;21(13):3953-9. doi: 10.3748/wjg.v21.i13.3953.
4
A comparison of statistical methods for the detection of hepatocellular carcinoma based on serum biomarkers and clinical variables.基于血清生物标志物和临床变量的肝细胞癌检测的统计方法比较。
BMC Med Genomics. 2013;6 Suppl 3(Suppl 3):S9. doi: 10.1186/1755-8794-6-S3-S9. Epub 2013 Nov 11.
5
Improved biomarker performance for the detection of hepatocellular carcinoma by inclusion of clinical parameters.通过纳入临床参数提高检测肝细胞癌的生物标志物性能。
Proceedings (IEEE Int Conf Bioinformatics Biomed). 2012 Dec;2012. doi: 10.1109/BIBM.2012.6392612.
6
Total serum glycan analysis is superior to lectin-FLISA for the early detection of hepatocellular carcinoma.血清总聚糖分析在肝细胞癌早期检测方面优于凝集素 - 荧光免疫分析。
Proteomics Clin Appl. 2013 Oct;7(9-10):690-700. doi: 10.1002/prca.201200125. Epub 2013 Sep 13.
7
Tumor marker requests in a general teaching Turkish hospital.土耳其一家普通教学医院的肿瘤标志物检测申请
Indian J Clin Biochem. 2007 Mar;22(1):52-6. doi: 10.1007/BF02912881.
8
Increased levels of tetra-antennary N-linked glycan but not core fucosylation are associated with hepatocellular carcinoma tissue.四触角 N-连接聚糖水平升高而非核心岩藻糖基化与肝癌组织相关。
Cancer Epidemiol Biomarkers Prev. 2012 Jun;21(6):925-33. doi: 10.1158/1055-9965.EPI-11-1183. Epub 2012 Apr 6.
9
Novel changes in glycosylation of serum Apo-J in patients with hepatocellular carcinoma.肝癌患者血清 Apo-J 糖基化的新变化。
Cancer Epidemiol Biomarkers Prev. 2011 Jun;20(6):1222-9. doi: 10.1158/1055-9965.EPI-10-1047. Epub 2011 Apr 5.
10
Linkage specific fucosylation of alpha-1-antitrypsin in liver cirrhosis and cancer patients: implications for a biomarker of hepatocellular carcinoma.肝硬化和癌症患者中α-1-抗胰蛋白酶的连接特异性岩藻糖基化：对肝细胞癌生物标志物的启示。
PLoS One. 2010 Aug 25;5(8):e12419. doi: 10.1371/journal.pone.0012419.
本文引用的文献
1
Studies of carcino-fetal proteins. 3. Development of a radioimmunoassay for -fetoprotein. Demonstration of -fetoprotein in serum of healthy human adults.癌胚蛋白研究。3. 甲胎蛋白放射免疫测定法的建立。健康成人血清中甲胎蛋白的证实。
Int J Cancer. 1971 Nov 15;8(3):374-83. doi: 10.1002/ijc.2910080304.
2
Radioimmunoassay of alpha-fetoprotein in primary and secondary cancer of the liver.原发性和继发性肝癌中甲胎蛋白的放射免疫测定
J Natl Cancer Inst. 1972 Sep;49(3):623-30.
3
Alpha-fetoprotein and hepatitis B antigen in acute hepatitis and primary cancer of the liver.急性肝炎和原发性肝癌中的甲胎蛋白与乙型肝炎抗原
Scand J Gastroenterol. 1973;8(3):197-202.
4
Radioimmunoassay of alpha-fetoprotein in human plasma.人血浆中甲胎蛋白的放射免疫测定
Lancet. 1973 Jun 16;1(7816):1355-7. doi: 10.1016/s0140-6736(73)91676-0.
5
Dependence of the specificity of the serologic test for primary liver cancer in different areas of the world on sensitivity of the method used for detecting alpha-fetoprotein.世界不同地区原发性肝癌血清学检测特异性对甲胎蛋白检测方法灵敏度的依赖性。
Int J Cancer. 1972 Sep 15;10(2):331-7. doi: 10.1002/ijc.2910100214.
6
Normal and increased alpha-fetoprotein in neoplastic and non-neoplastic liver disease.肿瘤性和非肿瘤性肝病中正常及升高的甲胎蛋白
Lancet. 1972 Aug 5;2(7771):278-9. doi: 10.1016/s0140-6736(72)91711-4.
7
Alpha-fetoprotein in normal and pregnancy sera.
Lancet. 1972 Feb 12;1(7746):375-6. doi: 10.1016/s0140-6736(72)92865-6.
8
Alpha-fetoprotein in ontogenesis and its association with malignant tumors.甲胎蛋白在个体发生中的作用及其与恶性肿瘤的关联。
Adv Cancer Res. 1971;14:295-358. doi: 10.1016/s0065-230x(08)60523-0.
Zotero 插件